Immunotherapy Following Bladder Cancer Surgery May Reduce Recurrence, Study Finds

Researchers from Memorial Sloan Kettering Cancer Center (MSK) found that patients who received the immunotherapy therapy nivolumab (Opdivo®) following...
Advertisement

Curated Journal reading List

Advertisement

Expert Interviews